An observational study of COPD-ST2OP

• Research type

  Research Study

• Full title

  An observational study of COPD-ST2OP

• IRAS ID

  275215

• Contact name

  Christopher Brightling

• Contact email

  ceb17@le.ac.uk

• Sponsor organisation

  University of Leicester

• Duration of Study in the UK

  5 years, 4 months, 0 days

• Research summary

  This will be a single-centre, observational study following completion of the COPD-ST2OP trial, which is a double-blinded, placebo-controlled, parallel group, randomised controlled trial (RCT) of anti-ST2 versus placebo in COPD (EudraCT ref: 2018-000919-24, clinialtrials.gov ID: NCT03615040). In this observational study participants will be followed up for up to 5 years and 6 months following completion of the COPD-ST2OP trial. Following completion in the COPD-ST2OP study participants will undertake three research visits followed by 5 years virtual data collection.

  The study will take place at the NIHR Leicester Biomedical Research Centre, Respiratory Unit, based at Glenfield Hospital Leicester. All participants who have completed the main COPD-ST2OP study will be invited to take part in this follow on observational study.

• REC name

  London - Brighton & Sussex Research Ethics Committee

• REC reference

  20/LO/0268

• Date of REC Opinion

  28 Feb 2020

• REC opinion

  Favourable Opinion